Campbell & CO Investment Adviser LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1353570 BALTIMORE, MD

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,046,547

+$5,645,961 QoQ

Shares Held

50,560

+343.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $29,502,691 across 9 Drug Manufacturers - General names. GILD ranks #1 (23.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	50,560	$7,046,547
2	LLY	ELI LILLY & Co	7,041	$6,476,100
3	NVS	Novartis AG	39,646	$6,055,926
4	AMGN	Amgen Inc	14,110	$4,964,603
5	BMY	Bristol Myers Squibb Co	29,424	$1,784,565
6	AZN	Astrazeneca PLC	8,338	$1,644,420
7	OGN	Organon & Co.	128,309	$768,570
8	GRFS	Grifols SA	63,848	$512,060

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,046,547	50,560	+343.1%	Shares	Sole	2026-05-15
2025-12-31	$1,400,586	11,411	-9.5%	Shares	Sole	2026-02-12
2025-09-30	$1,398,822	12,602	-56.3%	Shares	Sole	2025-10-28
2025-03-31	$3,228,160	28,810	+531.1%	Shares	Sole	2025-05-14
2024-03-31	$334,386	4,565	-38.6%	Shares	Sole	2024-05-10
2023-12-31	$602,390	7,436	+19.1%	Shares	Sole	2024-02-13
2023-09-30	$467,700	6,241	-18.9%	Shares	Sole	2023-11-08
2023-03-31	$638,869	7,700	-68.9%	Shares	Sole	2023-05-11
2020-09-30	$1,566,480	24,790	—	Shares	Sole	2020-10-15
No filing history on record for this holder in this stock.